Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 147,113 | 148,348 | 140,145 | 142,843 | 117,634 |
| Cost of Goods | 69,415 | 71,414 | 66,957 | 61,255 | 52,688 |
| Gross Profit | 77,698 | 76,934 | 73,188 | 81,588 | 64,946 |
| Operating Expenses | 97,343 | 119,236 | 37,836 | 40,881 | 514,792 |
| Operating Income | -19,230 | -41,888 | 36,309 | 40,962 | -449,158 |
| Other Income | 3,151 | 4,128 | 2,828 | 7,690 | 8,056 |
| Pre-tax Income | -16,079 | -37,760 | 39,137 | 48,652 | -441,102 |
| Income Tax | 2,688 | -8,878 | 6,101 | 3,590 | 8,854 |
| Net Income Continuous | -18,767 | -28,882 | 33,036 | 45,062 | -449,956 |
| Minority Interests | N/A | 904 | 117 | -70 | -15,038 |
| Net Income | $-18,767 | $-29,786 | $32,919 | $45,132 | $-434,918 |
| EPS Basic Total Ops | -0.50 | -0.79 | 0.86 | 1.18 | -11.37 |
| EPS Basic Continuous Ops | -0.50 | -0.77 | 0.86 | 1.18 | -11.76 |
| EPS Diluted Total Ops | -0.50 | -0.79 | 0.86 | 1.18 | -11.37 |
| EPS Diluted Continuous Ops | -0.50 | -0.77 | 0.86 | 1.18 | -11.76 |
| EBITDA(a) | $-10,705 | $-35,545 | $42,285 | $46,752 | $-443,587 |